2026.06.05 pancreatic cancer

[단단]

A new study has found that a pill called daraxonrasib is helping people with advanced pancreatic cancer live longer.

pancreatic 췌장의 

Researchers at the Universtiy of California, Los Angeles, say the drug blocks a mutated protein

that fuels tumor growth in more than 90 percent of pancreatic cancer cases.

mutate 돌연변이를 만들다. 

tumor 종양

Dr. Zev Wainberg, who led the study, says the daily pills nearly double survival time,

a median of 13.2 months, and with fewer side effects compared to additional chemotherapy.

median 중간의

chemotheraphy. 화학요법

oncology  종양학

0.8배는 잘 들리는데 1배는 어렵다